Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Neoplasms, Second Primary × Art Therapy × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Neoplasms 5 Anxiety Disorders 5 Breast Neoplasms 3 Pain 2 Vulvar Neoplasms 1 Vomiting 1 Uterine Neoplasms 1 Uterine Cervical Neoplasms 1 Stress, Psychological 1 Rectal Neoplasms 1 Personal Satisfaction 1 Ovarian Neoplasms 1 Neoplasms, Second Primary 1 Myasthenia Gravis 1 Malignant Solid Neoplasm 1 Hematopoietic and Lymphatic System Neoplasm 1 Femininity 1 Fatigue 1 Endometrial Neoplasms 1 Depression 1 Colonic Neoplasms 1 Cancer Pain 1

Interventions

Temozolomide 2 Radiosurgery 2 Leucovorin 2 Irinotecan 2 Fluorouracil 2 sacubitril and valsartan sodium hydrate drug combination 1 icotinib 1 dostarlimab 1 beta Carotene 1 avelumab 1 alpha-Tocopherol 1 Varenicline 1 Tobacco Use Cessation Devices 1 Therapeutics 1 Thalidomide 1 Radiotherapy 1 Probiotics 1 Panitumumab 1 Nicotine Chewing Gum 1 Myofascial Release Therapy 1 Megestrol Acetate 1 Isotretinoin 1 Folfox protocol 1 Drug Therapy 1 Doxycycline 1 Docetaxel 1 Cryosurgery 1 Clonidine 1 Cetuximab 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04195217 2021-12-17

ARONCO

Centre Hospitalier de Perigueux

Phase NA Unknown

Neoplasms, Neoplasms, Second Primary

Data powered by HemOnc (CC BY 4.0) Colophon ⚡